• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2100088 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2021-01-22 Pharmacyclics LLC Pharmacyclics Inc In Review 2021-01-21 view
JYHB2001826 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-09-19 Pharmacyclics LLC Pharmacyclics Inc In Review 2020-09-18 view
JYHB2000627 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-05-25 Pharmacyclics LLC Pharmacyclics Inc Filed 2020-06-04 view
JYHB2000345 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-04-10 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2020-06-12 view
JYHB2000254 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2020-03-14 Pharmacyclics LLC Pharmacyclics Inc Filed 2020-03-26 view
JYHB1900203 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2019-02-22 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2019-04-04 view
JYHB1800207 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(5.1) Supplementary Application 2018-03-05 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2018-11-09 view
JYHB1701213 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(5.1) Supplementary Application 2017-09-26 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2018-07-06 view
JYHB1701174 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2017-09-18 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2018-04-18 view
JYHB1701171 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs Supplementary Application 2017-09-11 Pharmacyclics LLC Pharmacyclics Inc Filed 2017-09-25 view
JXHS1600066 伊布替尼胶囊 ibrutinib Capsule Chemical Drugs(5.1) Import Drug Application 2016-11-07 Pharmacyclics LLC Pharmacyclics Inc Certificate Issued 2017-08-28 view